cefodizime has been researched along with cefuroxime in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grassi, C | 1 |
| Constantoulaki, S; Dimopoulou, H; Paniara, O; Platsouka, E | 1 |
| Härtl, A; Mrestani, Y; Neubert, R; Schiewe, J | 1 |
| Bartunek, A; Graninger, W; Hiesmayr, M; Parschalk, B; Pernerstorfer, T; Wenisch, C; Zedtwitz-Liebenstein, K | 1 |
| Brandsch, M; Luckner, P | 1 |
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
2 trial(s) available for cefodizime and cefuroxime
| Article | Year |
|---|---|
[Infections of the lower respiratory tract: clinical experimentation with a new cephalosporin].
Topics: Adjuvants, Immunologic; Cefotaxime; Cefuroxime; Humans; Injections, Intramuscular; Injections, Intravenous; Respiratory Tract Infections; Time Factors | 1994 |
Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting.
Topics: Aged; Cefotaxime; Cefuroxime; Cephalosporins; Coronary Artery Bypass; Escherichia coli; Female; Humans; Intraoperative Care; Male; Middle Aged; Monitoring, Physiologic; Neutrophils; Phagocytosis; Prospective Studies; Reactive Oxygen Species; Staphylococcus aureus | 1997 |
7 other study(ies) available for cefodizime and cefuroxime
| Article | Year |
|---|---|
In vitro evaluation of cefodizime, cefuroxime, ceftriaxone against respiratory pathogens.
Topics: Cefotaxime; Ceftriaxone; Cefuroxime; Haemophilus Infections; Haemophilus influenzae; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae | 1994 |
Application of capillary zone electrophoresis in cephalosporin analysis.
Topics: Cefotaxime; Cefpirome; Cefuroxime; Cephalosporins; Electrophoresis, Capillary; Hydrogen-Ion Concentration | 1997 |
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2005 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |